Research Alliance Corp IV Closes $75M IPO, Begins Trading on Nasdaq
RACD is trading near its 52-week low of $10.31 (1.1% above the low) on light trading volume (0.2× avg).
Summary
Research Alliance Corp IV closed its $75 million IPO on July 14, 2026, and its shares began trading on Nasdaq under ticker RACD. The SPAC will now seek a healthcare business combination within 24 months.
Key Events · Financing and Capital Events · RACD
-
IPO Closes at $10.00 Per Share
The company sold 7.5 million Class A ordinary shares at $10.00 each, generating $75 million in gross proceeds. Shares began trading on Nasdaq under ticker RACD on July 13, 2026.
-
Sponsor Private Placement
Concurrently with the IPO, the sponsor purchased 275,000 private placement shares at $10.00 per share, adding $2.75 million to the trust account.
-
Trust Account Funded
$75 million (including the underwriter's deferred commission of $2.25 million) was deposited into a trust account, to be used for a future business combination or returned to shareholders if no deal is completed within 24 months.
-
Board and Committee Appointments
Alan Musso and John Maslowski were appointed to the board of directors and its audit, nominating, and compensation committees, effective July 10, 2026.
Analysis · RACD · Real Estate & Construction
Research Alliance Corp IV completed its initial public offering, raising $75 million by selling 7.5 million units at $10.00 each. The SPAC, sponsored by an affiliate of RA Capital Management, will now search for a healthcare or healthcare-related business to acquire. The IPO provides the company with a substantial trust account to fund a future business combination, but as a blank-check company, it currently has no operations. The offering's success signals investor confidence in the management team's ability to identify and execute a deal, though the 24-month deadline to complete a transaction introduces execution risk.
At the time of this filing, RACD was trading at $10.42 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $108.6M. The 52-week trading range was $10.31 to $10.68. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.